QUE — Spinal Muscular Atrophy Newborn Screening Test System Class II
FDA product code QUE covers "Spinal Muscular Atrophy Newborn Screening Test System", a Class II medical device regulated under 21 CFR 866.5980. Submissions are reviewed by the Immunology panel. At least 2 recent 510(k) clearances have been granted under this product code.
Classification details
- Product Code
- QUE
- Device Class
- Class II
- Regulation Number
- 866.5980
- Submission Type
- 510(k)
- Review Panel
- MG
- Medical Specialty
- Immunology
- Implant
- No
Definition
A Spinal Muscular Atrophy (SMA) newborn screening test system is a prescription device intended to detect homozygous deletion of exon 7 or other similar mutations in the SMN1 (Survival Motor Neuron 1) gene of DNA obtained from dried blood spot specimens on filter paper using a polymerase chain reaction-based test as an aid in screening newborns for SMA. Presumptive positive results are intended to be followed up by diagnostic confirmatory testing.